BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 21624624)

  • 1. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
    van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
    J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated brain iron is independent from atrophy in Huntington's Disease.
    Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
    Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
    van den Bogaard SJ; Dumas EM; Acharya TP; Johnson H; Langbehn DR; Scahill RI; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA;
    J Neurol; 2011 Mar; 258(3):412-20. PubMed ID: 20936300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional subcortical shape analysis in premanifest Huntington's disease.
    Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
    Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.
    Harris GJ; Pearlson GD; Peyser CE; Aylward EH; Roberts J; Barta PE; Chase GA; Folstein SE
    Ann Neurol; 1992 Jan; 31(1):69-75. PubMed ID: 1531910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
    Douaud G; Gaura V; Ribeiro MJ; Lethimonnier F; Maroy R; Verny C; Krystkowiak P; Damier P; Bachoud-Levi AC; Hantraye P; Remy P
    Neuroimage; 2006 Oct; 32(4):1562-75. PubMed ID: 16875847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.
    Reetz K; Romanzetti S; Dogan I; Saß C; Werner CJ; Schiefer J; Schulz JB; Shah NJ
    Neuroimage; 2012 Oct; 63(1):517-24. PubMed ID: 22796981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
    Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease.
    Saft C; Schüttke A; Beste C; Andrich J; Heindel W; Pfleiderer B
    Neuropsychologia; 2008 Apr; 46(5):1279-89. PubMed ID: 18221758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
    Georgiou-Karistianis N; Poudel GR; Domínguez D JF; Langmaid R; Gray MA; Churchyard A; Chua P; Borowsky B; Egan GF; Stout JC
    Brain Cogn; 2013 Oct; 83(1):80-91. PubMed ID: 23938592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural involvement of the cingulate cortex in premanifest and early Huntington's disease.
    Hobbs NZ; Pedrick AV; Say MJ; Frost C; Dar Santos R; Coleman A; Sturrock A; Craufurd D; Stout JC; Leavitt BR; Barnes J; Tabrizi SJ; Scahill RI
    Mov Disord; 2011 Aug; 26(9):1684-90. PubMed ID: 21557312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.
    Georgiou-Karistianis N; Gray MA; Domínguez D JF; Dymowski AR; Bohanna I; Johnston LA; Churchyard A; Chua P; Stout JC; Egan GF
    Neurobiol Dis; 2013 Mar; 51():82-92. PubMed ID: 23069680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).
    Amann M; Andělová M; Pfister A; Mueller-Lenke N; Traud S; Reinhardt J; Magon S; Bendfeldt K; Kappos L; Radue EW; Stippich C; Sprenger T
    Neuroimage Clin; 2015; 7():43-52. PubMed ID: 25610766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal metabolite changes in Huntington's disease during disease onset.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; van Buchem MA; Roos RA; van der Grond J
    J Huntingtons Dis; 2014; 3(4):377-86. PubMed ID: 25575959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional MRI study of a serial reaction time task in Huntington's disease.
    Kim JS; Reading SA; Brashers-Krug T; Calhoun VD; Ross CA; Pearlson GD
    Psychiatry Res; 2004 May; 131(1):23-30. PubMed ID: 15246452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Texture analysis of ultrahigh field T2*-weighted MR images of the brain: application to Huntington's disease.
    Doan NT; van den Bogaard SJ; Dumas EM; Webb AG; van Buchem MA; Roos RA; van der Grond J; Reiber JH; Milles J
    J Magn Reson Imaging; 2014 Mar; 39(3):633-40. PubMed ID: 23723108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.